Items tagged with Access
Janssen Pharmaceutica to expand production of Sirturo in Russia (post)
Janssen Pharmaceutica, which is part of US healthcare giant Johnson & Johnson, plans to increase production of its Sirturo (bedaquiline) – an anti-tuberculosis drug – in Russia, at the capacities of a local drugmaker Pharmstandard, according to recent statements of the companies, reports The Pharma Letter’s local correspondent.
Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant TB (post)
SETTING
New TB tools need to be affordable in the private sector: The case study of Xpert MTB/RIF (post)
A new 13-country patient pathway analysis published in the Journal of Epidemiology and Global Health presents updated data on what patients pay for Xpert MTB/RIF testing in the private health sector in highly privatized health markets.
MPP presents new five-year strategy for improving access to priority treatments in developing countries (post)
Strategy and related feasibility study call for the expansion of the MPP’s mandate to patented medicines on the World Health Organization’s Model List of Essential Medicines
South Africa takes landmark step for access to medicines (post)
MSF applauds effort to ‘take off patent blindfold’ and change patent laws to increase access to affordable medicines
UN HLM on TB Key Ask 1: 40 million by 2022 (post)
One of the main targets for the UN High-Level Meeting on TB (UN HLM on TB) is to get 40 million people diagnosed and on proper TB treatment by the end of 2022.
South Africa: the country where political leadership serves the people (post)
In an unprecedented and historic move, South African Department of Health decided to recommend including bedaquiline as the standard treatment for patients with drug-resistant TB (DR-TB). The country also released data showing that treatment regimens including bedaquiline reduced mortality three-fold compared with those without bedaquiline.
Kanchan Mukherjee: Bedaquiline for multidrug-resistant TB in India — at what cost? (post)
In a blog post in The BMJ Opinion, Kanchan Mukherjee, a medical doctor and professor at the Tata Institute of Social Sciences in Mumbai, discusses the potential benefits and challenges of a wider government rollout of bedaquiline to treat multidrug-resistant TB in India.
Community health workers crucial in fight against TB (post)
An article published in Chronicle reviews the political commitment in Zimbabwe to raise awareness about TB through community TB care approach.
At last minute, countries pressured to drop language on protecting access to affordable medicines from TB Summit declaration negotiations (post)
New York, 20 July 2018 — Countries negotiating the final declaration text for the first-ever UN High-level Meeting on Tuberculosis in September are being put under significant pressure to drop all references to protecting countries’ rights to take fully-legal actions to access affordable medicines for their people, Médecins Sans Frontières reported learning today.
Page 33 of 83 · Total posts: 0
←First 32 33 34 Last→